Scout Achieves Notable Debut on Inc. 5000's Fastest Growing Companies List

Scout's Remarkable Recognition on Inc. 5000

In a momentous announcement, Scout, a distinguished provider in the pharmaceutical and biotechnology sectors, has made its debut on the notable Inc. 5000 list for 2025. This prestigious ranking, which highlights America’s fastest-growing private companies, serves as a testament to Scout's sustained growth and innovative services.

Acknowledging the Achievement

Scout's CEO, Moisha Platto, remarked on this achievement, emphasizing that it transcends mere vanity metrics. He noted, “It confirms to us that pairing real human know-how with tech that actually works means we can scale without sacrificing what matters—compliant, on-time support for every participant, every site, every meeting, everyone along the way.” This sentiment underpins the core philosophy of Scout’s operational strategy, which focuses on delivering value while maintaining high standards of service.

The Growth Strategy

Scout’s impressive growth is attributed to its unwavering commitment to three critical promises:

1. Reducing Site Load: Scout’s services enable coordinators to reclaim valuable hours previously consumed with logistical tasks such as booking travel and processing payments, allowing them to redirect their focus toward scientific endeavors and patient care.

2. Investing Ahead of Demand: Through ongoing enhancements to the Scout Portal and the ScoutPass debit card program, users can access round-the-clock control over travel arrangements and payment options in a variety of currencies and languages. This has empowered participants on a global scale with the tools needed for seamless interactions.

3. Facilitating Global Studies: By offering a single partner to manage the flow of individuals and funds across borders, Scout ensures compliance with stringent data privacy and banking regulations. This approach streamlines operations, which is immensely beneficial for trial sponsors and contract research organizations (CROs).

Overall, Scout's dedication to protecting timelines and budget constraints is evident. It systematically eliminates bottlenecks, thereby granting site staff valuable time back, ultimately leading to improved efficiency and expedited patient access to care.

Impact on Clients and Patients

Scout operates with the understanding that true growth does not necessitate a compromise on service quality or trust. This recognition from Inc. 5000 showcases meaningful progress in mitigating delays and lightening the load of manual operations—further enhancing the company’s support for everything from participant reimbursements to investigator meetings. Scout's partners have long recognized its ability to deliver scalable solutions without reductions in service levels, a sentiment reinforced by this accolade.

A Legacy of Empowerment

Celebrating 30 years of excellence in clinical trial empowerment, Scout has been a beacon of innovative solutions and robust technology. With operations spanning over 100 countries, Scout facilitates various types of meeting planning—face-to-face, virtual, and hybrid—along with patient payment and logistics support for premier pharmaceutical and biotechnology firms. To explore more about Scout’s legacy and service offerings, interested parties can visit scoutclinical.com.

About Inc.

Inc. magazine remains a defining media brand and influential guide for entrepreneurs and business leaders shaping contemporary and future landscapes. The publication aims to educate and elevate the profiles of innovators and risk-takers who lead the business scene. Managed by Mansueto Ventures LLC, Inc. along with its allied publication, Fast Company, champions the esprit de corps of its community. More information about Inc. is available at www.inc.com.

As Scout continues its journey, this ranking is not just a highlight of past accomplishments but is also a beacon of potential future innovations and growth within the pharma and biotech industries.